US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) ...

The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...

Shares in Kronos Bio, a US biotech that has been developing small molecule therapeutics to address cancers and other diseases ...

US biotech major Amgen (Nasdaq AMGN) late Thursday announced financial results for the first quarter of 2025, revealing that ...